Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-013096

Director acquired 1,093 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Caroline Director 2023-09-05 Other acquisition 10b5-1 +65 $1.68 $109 21,399 D
Young Caroline Director 2023-09-06 Other acquisition 10b5-1 +65 $1.65 $107 21,464 D
Young Caroline Director 2023-09-07 Other acquisition 10b5-1 +65 $1.68 $109 21,529 D
Young Caroline Director 2023-09-08 Other acquisition 10b5-1 +65 $1.68 $109 21,594 D
Young Caroline Director 2023-09-11 Other acquisition 10b5-1 +65 $1.71 $111 21,659 D
Young Caroline Director 2023-09-12 Other acquisition 10b5-1 +65 $1.76 $114 21,724 D
Young Caroline Director 2023-09-13 Other acquisition 10b5-1 +65 $1.83 $119 21,789 D
Young Caroline Director 2023-09-14 Other acquisition 10b5-1 +65 $1.84 $120 21,854 D
Young Caroline Director 2023-09-15 Other acquisition 10b5-1 +23 $1.82 $42 21,877 D
Young Caroline Director 2023-09-18 Other acquisition 10b5-1 +55 $2.03 $112 21,932 D
Young Caroline Director 2023-09-19 Other acquisition 10b5-1 +55 $2.12 $117 21,987 D
Young Caroline Director 2023-09-20 Other acquisition 10b5-1 +55 $2.14 $118 22,042 D
Young Caroline Director 2023-09-21 Other acquisition 10b5-1 +55 $2.28 $125 22,097 D
Young Caroline Director 2023-09-22 Other acquisition 10b5-1 +55 $2.29 $126 22,152 D
Young Caroline Director 2023-09-25 Other acquisition 10b5-1 +55 $2.24 $123 22,207 D
Young Caroline Director 2023-09-26 Other acquisition 10b5-1 +55 $2.07 $114 22,262 D
Young Caroline Director 2023-09-27 Other acquisition 10b5-1 +55 $1.98 $109 22,317 D
Young Caroline Director 2023-09-28 Other acquisition 10b5-1 +55 $1.96 $108 22,372 D
Young Caroline Director 2023-09-29 Other acquisition 10b5-1 +55 $1.90 $105 22,427 D
Loading xslF345X05/marketforms-62746.xml…